Ablynx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Ablynx and buy or sell other stocks, ETFs, and their options commission-free!About ABLX
Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology.
CEOGeert Deschamps
CEOGeert Deschamps
Employees—
Employees—
HeadquartersGhent, Flemish Region
HeadquartersGhent, Flemish Region
Founded2001
Founded2001
Employees—
Employees—
ABLX Key Statistics
Market cap3.95B
Market cap3.95B
Price-Earnings ratio-26.12
Price-Earnings ratio-26.12
Dividend yield—
Dividend yield—
Average volume3.44K
Average volume3.44K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$55.29
52 Week high$55.29
52 Week low$17.75
52 Week low$17.75
Stock Snapshot
Ablynx(ABLX) stock is priced at $52.76, giving the company a market capitalization of 3.95B. It carries a P/E multiple of -26.12.
On 2025-12-08, Ablynx(ABLX) stock opened at —, reached a high of —, and a low of —.
The Ablynx(ABLX)'s current trading volume is 0, compared to an average daily volume of 3.44K.
In the last year, Ablynx(ABLX) shares hit a 52-week high of $55.29 and a 52-week low of $17.75.
In the last year, Ablynx(ABLX) shares hit a 52-week high of $55.29 and a 52-week low of $17.75.